Relationship between angiotensin II receptor expression and cardiovascular risk factors in Mexican patients with coronary occlusive disease-Reference-Cited by-同舟云学术

Relationship between angiotensin II receptor expression and cardiovascular risk factors in Mexican patients with coronary occlusive disease

Published:2011-08 Issue:1 Volume:91 Page:478-483
ISSN:0014-4800
Container-title:Experimental and Molecular Pathology
language:en
Short-container-title:Experimental and Molecular Pathology

Author:

Baños Manuel,Arellano-Mendoza Monica G.,Vargas-Robles Hilda,Avila-Casado M. Carmen,Soto Virgilia,Romo Eunice,Rios Amelia,Hernandez-Zavala Araceli,la Peña-Diaz Aurora de,Escalante Bruno

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Pathology and Forensic Medicine

Reference28 articles.

1. Exploring AT(1) and AT(2) angiotensin II receptors in humans;Aldigier;Drugs,2002

2. Population-based case-control study of renin–angiotensin system genes polymorphisms and hypertension among Hispanics;Bautista;Hypertens Res,2008

3. Angiotensin II and vascular inflammation;Cheng;Med Sci Monit,2005

4. Pharmacology of angiotensin receptors and AT1 receptor blockers;Chung;Basic Res Cardiol,1998

5. Cell biology and genetics of angiotensin in cardiovascular disease;Dzau;J Hypertens Suppl,1994

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling;Hypertension;2021-06

2. UPLC-MS-Based Serum Metabolomics Reveals Potential Biomarkers of Ang II-Induced Hypertension in Mice;Frontiers in Cardiovascular Medicine;2021-05-05

3. Protective effect of angiotensin II receptor blocker against oxidative stress and inflammation in an oral mucositis experimental model;Journal of Oral Pathology & Medicine;2018-09-19

4. Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease;Clinical Science;2016-06-29

5. Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics;Frontiers in Pharmacology;2015-08-25